Research Paper Volume 13, Issue 16 pp 20585—20597

Prognostic and clinicopathological significance of systemic immune-inflammation index in pancreatic cancer: a meta-analysis of 2,365 patients

class="figure-viewer-img"

Figure 3. Forest plot reflecting the association between SII and RFS/PFS/DFS in pancreatic cancer. (HR=1.52, 95%CI=1.01-2.28, p=0.045). SII= systemic immune-inflammation index, RFS=recurrence-free survival, DFS= disease-free survival, PFS = progression-free survival.